SIRT6 activates extracellular signal‐regulated kinase 1/2 (ERK1/2) in non‐small cell lung carcinoma and osteosarcoma to drive metastatic spread via MMP9 upregulation [20, 28, 29]. The gene discussed is SIRT6; the disease is osteosarcoma.